Pricing

Pricing built around your trial

Our weekly trial analytics are priced against what a delayed or failed trial costs. Every study is different, so we scope the price to yours.

The cost of delay

What a missed trial actually costs

About half of all trials don't recruit enough people on time. For a drug that reaches the market, each day of delay means about $500,000 in sales that never happen, on average. Running a Phase II or III trial also costs about $40,000 a day. Small slips in site activation, enrollment, engagement, and retention add up fast. Our weekly reports flag those slips early so your team can win the time back. PING, the software we are building, will do this automatically.

1 day of delay

~$500,000

in lost sales per day, for a drug that reaches the market

Direct operational cost

~$40,000

per day to run a Phase II or III trial

PING goal

Recover time

before delays compound into missed outcomes

Sources: Tufts Center for the Study of Drug Development (CSDD), 2024; Parker A, et al., Cochrane Database of Systematic Reviews, 2026

20%
Delay days avoided
Estimated value of avoiding them
Get a free Enrollment Risk Check
An estimate for planning, not a guarantee. Results depend on your study, your data, and how quickly your team acts.
Sources: direct daily cost by phase from Tufts CSDD, Quantifying the Value of a Day of Delay in Drug Development (2024); average daily sales of marketed drugs about $500,000 (same source); likelihood of approval by phase from BIO, Informa and QLS, Clinical Development Success Rates 2011–2020 (2021). These figures are for drug trials. For device trials, enter your own daily cost. For grant-funded studies, the cost comes from the budget you enter.

How to work with PING

Three ways to work with PING

Monitor

See trouble the week it starts.

A weekly early-warning report for a single trial

Pace and drift alerts

Scoped to your study

Talk to us

Managed

We run it as your analytics team.

Everything in Predict & Guide

Multi-trial portfolio view

Staff training and site-readiness monitoring

Independent trial review

Dedicated support

Scoped to your study

Talk to us
How pricing works

Clear parts, priced to your study

Trials differ too much in phase and scale for one list price. Every quote is built from the same parts below, and you get it in writing before you commit.

One-time fee

Setup

We connect your data sources and build your study's risk model.

Per trial, per month

Monthly

Set by plan and study size, for your planned enrollment period and at least 6 months.

Design partners

Pilot

A 60-day pilot at a reduced fee. If you continue, the pilot fee counts toward your first months.

Academic, nonprofit, sites

Lower rates

For academic, nonprofit and government-funded studies, and for research sites.

PING plus HEOR or RWE

Bundles

Pair PING with our HEOR or real-world evidence work and pay less than separate quotes.

Start here

Free Risk Check

Start with one study at no cost. You get a short report within 10 business days.

Request my Risk Check →

Every engagement includes

Built to help teams act sooner

Whatever level you choose, every engagement is built to show risk earlier, help your team act faster, and measure what changed.

Trial risk monitoring

Enrollment visibility and tracking

Early warning alerts

Actionable recommendations

Intervention tracking

Secure data management

Onboarding and implementation support

FAQs

Everything you need to know

Each engagement is scoped to your study and measured against what a delayed trial costs. You get the price in writing before you commit.

Trials differ too much in phase and scale for one price to fit. Scoping to your study means you pay for what your trial actually needs.

Monitor gives you a weekly early-warning report for one trial. Predict & Guide adds forecasts, root-cause analysis, and ranked next steps. Managed adds a view across all your trials, and we run the work as your analytics team.

Trial risk monitoring, enrollment visibility, early-warning alerts, actionable recommendations, intervention tracking, secure data management, and onboarding support.

About $500,000 in unrealized sales per day, plus around $40,000 in direct operational cost, according to the Tufts Center for the Study of Drug Development (2024).

Tell us about your trial through the contact form. We'll scope a price and show you the value behind it.

Tell us about your trial.

Share the basics and we’ll scope a price and show you the value behind it.

Request a quote
CONTACT US

Let's talk about your study

Tell us a little about your study and what you need. We'll reply by email with a clear next step. You can also write to us at hello@mastertable.com. Please don't send patient data through this form.

Full Name*

Error

Email*

Error

Phone (optional)

Error

I'm interested in

Error

Tell us more

Error
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.